pretty positive. focus well and truly on CBD. Like the pipeline and who we are working with. What is not mentioned is the ability to license the technology in this field. Really chance to grow to 3-4 cents.
Animal Feed is interesting but once bitten twice shy. It's taken 3-4 years to get to the stage where we can say there is a specific company conducting trials!!!
Injectables are done and dusted. As are patches. Surely if there is a legitimate company investigating then AVE can mention their name. It would also have a much higher target price than 6.6c if Human health was a goer. Propofol and Daptymicin not even mentioned.
Ann: June 2021 Quarterly Activities Report & Appendix 4C, page-2
Add AVE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $12.67M | |||
| Open | High | Low | Value | Volume |
| 0.4¢ | 0.4¢ | 0.3¢ | $10.88K | 2.730M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 34 | 96872579 | 0.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.4¢ | 15583245 | 12 |
View Market Depth
| Last trade - 16.10pm 09/05/2024 (20 minute delay) ? |
|
|||||
|
Last
0.4¢ |
Change
0.000 ( 33.3 %) |
||||
| Open | High | Low | Volume | ||
| 0.3¢ | 0.4¢ | 0.3¢ | 909600 | ||
| Last updated 14.54pm 09/05/2024 ? | |||||
| AVE (ASX) Chart |